RNAi
October 1, 2019
Building for Our Future
Why would a company without a commercially approved medicine decide to build a significant manufacturing facility? Why not continue to rely on contract...
Read More ›
May 12, 2019
What is RNAi and How Do RNAi Therapeutics Work?
What is RNAi? This video explains how Alnylam is leading the translation of RNAi to create an entirely new class of innovative medicines to treat disease.
Read More ›
February 20, 2019
Alnylam Named a Fast Company World's Most Innovative Company for 2019
Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019.
Read More ›
January 3, 2019
John Maraganore Talks RNAi on Chemical & Engineering News Podcast
John Maraganore talks with Chemical & Engineering News' Lisa Jarvis and Ryan Cross on this episode of C&EN's Stereo Chemistry podcast.
Read More ›
May 9, 2018
First Rounders: John Maraganore
Our CEO John Maraganore, Ph.D. recently chatted with the Nature Biotechnology Podcast about his path into science, through research and ultimately into biotech.
Read More ›
April 30, 2018
Hunting for Targets: Bringing RNAi to Humans
Evolution is a powerful force, and Mother Nature is often a great source of inspiration for drug hunters like me. If you look at the history of successful...
Read More ›
April 30, 2018
Building to Scale: Raising RNAi Therapeutics From Infancy
When I joined Alnylam in 2004, one of our early challenges was figuring out how to manufacture and deliver RNAi therapeutics for our clinical trials. The...
Read More ›
February 28, 2018
Harnessing the Power of RNAi™: Pushing Through the Challenges and Setbacks
I am an organic chemist, and what keeps me going after 3 decades working in the field of oligonucleotides is transforming complex chemistry into medicines...
Read More ›
February 28, 2018
RNAi Therapeutics: From Eureka! Moment to a Potential New Class of Medicines
How far science and technology have come! At Alnylam, we believe we’re on the verge of a landmark moment in medicine and I can’t help but express my...
Read More ›
